MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by BWX Technologies, Inc.

< Previous 1 2 3 Next >
BWXT Awarded Contract to Evaluate Microreactor Deployment for State of Wyoming
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT to Manufacture HALEU Feedstock for Advanced Reactors
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWX Technologies Reports Second Quarter 2023 Results
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT Awarded an Engineering Contract from TerraPower for the Natrium™ Demonstration Project
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT to Provide Nuclear Reactor Engine and Fuel for DARPA Space Project
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWX Technologies to Announce Second Quarter 2023 Results on Thursday, August 3
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWX Technologies Reports First Quarter 2023 Results
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT-led Team Awarded $45 Billion Environmental Management Contract for DOE’s Hanford Site
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT Subsidiary Awarded $428 Million Contract for Uranium Conversion and Purification Services
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWX Technologies to Announce First Quarter 2023 Results on Monday, May 8
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT Awarded Engineering Contract from GE Hitachi for BWRX-300 Small Modular Reactor
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT Releases 2023 Sustainability Report
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWX Technologies Reports Fourth-Quarter and Full-Year 2022 Results, Initiates 2023 Guidance and Increases Quarterly Cash Dividend
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT Medical and Laurentis Complete Key Tc-99m Generator Program Milestone
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWX Technologies to Announce Fourth Quarter and Full-Year 2022 Results on Thursday, February 23
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
Fusion Pharmaceuticals and BWXT Medical Announce Actinium-225 Partnership to Scale Supply for Developing Targeted Alpha Therapies
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT Promotes Chip Whitford to Senior Vice President and General Counsel
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT Starts Production of TRISO Fuel for First U.S. Generation IV Microreactor
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWX Technologies Reports Third Quarter 2022 Results
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT to Participate in Upcoming Investor Conferences
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT Closes Amended and Restated Credit Agreement
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWX Technologies to Announce Third Quarter 2022 Results on Monday, November 7
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT Medical Submits Tc-99m Generator New Drug Application to FDA
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT Names Robert Duffy as Chief Administrative Officer
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWX Technologies Reports Robust Second Quarter 2022 Results; Increases 2022 Revenue and Adjusted EBITDA(1) Guidance
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT Names Sharon H. Smoot as President of Nuclear Operations Group
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWX Technologies to Announce Second Quarter 2022 Results on Monday, August 8
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT Canada Awarded CA$130 Million Component Manufacturing Contract from Bruce Power
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT Medical Executes Commercial Agreement with Bayer for Supply of Actinium-225 Based Products
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
BWXT Medical and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products
From BWX Technologies, Inc.
Via Business Wire
Tickers BWXT
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
TOP
Email a Story